As a second COVID-19 vaccine moves closer to joining the U.S. fight against the pandemic, Venture Technology Editor Dave Lashmet discusses who should be first in line... and why the '50/50 rule' should be used.

ICYMI: Dave dug deeper into Pfizer's vaccine data and revealed a surprise overlooked by the media:    • Exclusive: One Dose Is Enough - The S...  

He also discussed the question nobody is asking about the vaccine:    • The Question Nobody's Asking About th...  

Get the same tools used by the world's elite investors today! Sign up for free! - https://stansberryinvestor.com/home
______________________________

Follow us on Facebook:   / stansberryresearch  
Follow us on Twitter:   / stansberry  
Follow us on Instagram:   / stansberry_research  
Follow us on LinkedIn:   / stanberry-research